Schedule 13G ownership disclosure
Entrada Therapeutics Inc
Security class unavailable · CUSIP: 29384C108
Event date: 2021-11-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,704,419
- Percent of class
- 15.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-137008
- Form type
- SC 13G
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Nov 10, 2021
- Reporting period
- Nov 02, 2021
- Description
- Schedule 13G beneficial ownership